Molecure S.A. (WSE:MOC)
7.29
+0.07 (0.97%)
At close: Dec 5, 2025
Molecure Revenue
Molecure had revenue of 214.80K PLN in the quarter ending September 30, 2025, a decrease of -63.83%. This brings the company's revenue in the last twelve months to 5.86M, up 459.10% year-over-year. In the year 2024, Molecure had annual revenue of 2.92M, down -20.08%.
Revenue (ttm)
5.86M
Revenue Growth
+459.10%
P/S Ratio
25.64
Revenue / Employee
82.49K
Employees
102
Market Cap
150.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.92M | -733.54K | -20.08% |
| Dec 31, 2023 | 3.65M | -3.86M | -51.39% |
| Dec 31, 2022 | 7.51M | 6.35M | 543.32% |
| Dec 31, 2021 | 1.17M | -123.74M | -99.07% |
| Dec 31, 2020 | 124.91M | 122.90M | 6,100.72% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |